Epidemiologia. Esiintyvyys ja ilmaantuvuus. Valtaosalla v. Diastolisen verenpaineen keskiarvo suurenee noin 5. Kansallinen FINRISKI 2. Osa 2: Tutkimuksen taulukkoliite. Terveyden ja hyvinvoinnin laitos, Raportti 2. Retrouvez toutes les discothèque Marseille et se retrouver dans les plus grandes soirées en discothèque à Marseille. Find patient medical information for WHEY PROTEIN on WebMD including its uses, effectiveness, side effects and safety, interactions, user ratings and products that. Terveys, toimintakyky ja hyvinvointi Suomessa 2. Terveyden ja hyvinvoinnin laitos. Verenpainetasot ja hoitotasapaino FINRISKI- tutkimusalueilla 1. Trends in hypertension care in eastern and south- western Finland during 1. J Hypertens 2. 00. Puska P, Vartiainen E, Laatikainen T, Jousilahti P, Paavola M (toim.).
The North Karelia Project: From North Karelia to national action. Terveyden ja hyvinvoinnin laitos. Helsinki University Printing »7, «Vartiainen E, Laatikainen T, Tapaninen H ym. Verenpaineen aleneminen pys. Cartolina dalla vacanza. Design by Gio&Vi Mitopositano com - News Manciano - Saturnia - indexvecchia - index cogn - Hotels of the world - Agriturismi Vacanze. However, an eligible body of scientific evidence unravels notable diabetes-mediating garcinia side effects -some of them closely resemble the documented diabetes. Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women. Stampfer, M.D., Graham Colditz. Kohonnut verenpaine on maailmanlaajuisesti merkittävin terveitä elinvuosia vähentävä riskitekijä ja aiheuttaa vuosittain noin 9,4 miljoonaa ennenaikaista kuolemaa. Alenema oli kaikilla miehill. Terveys, toimintakyky ja hyvinvointi Suomessa 2. Terveyden ja hyvinvoinnin laitos. FINRISKI 2. 01. 2 - tutkimuksen mukaan diastolinen verenpaine on miehill. Verenpainetasot ja hoitotasapaino FINRISKI- tutkimusalueilla 1. Terveys, toimintakyky ja hyvinvointi Suomessa 2. Terveyden ja hyvinvoinnin laitos. Adding a low- dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncompl»9, «KELA, julkaisematon rekisteritieto.»1. Vastaavasti vuonna 2. KELA, julkaisematon rekisteritieto.»1. Terveys, toimintakyky ja hyvinvointi Suomessa 2. Terveyden ja hyvinvoinnin laitos. Verenpainetasot ja hoitotasapaino FINRISKI- tutkimusalueilla 1. Prevalence, awareness and treatment of hypertension in Finland during 1. J Hypertens 2. 00. Vaikka aiemmassa hoitotavoitteessa (< 1. Hg) olevien osuus on viimeisen 1. Koskinen S, Lundqvist A, Ristiluoma N. Terveys, toimintakyky ja hyvinvointi Suomessa 2. Terveyden ja hyvinvoinnin laitos. Verenpainetasot ja hoitotasapaino FINRISKI- tutkimusalueilla 1. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dil»1. Alderman MH. Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med 1. Lewington S, Clarke R, Qizilbash N ym. Age- specific relevance of usual blood pressure to vascular mortality: a meta- analysis of individual data for one million adults in 6. Kohonnut verenpaine lyhent. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation 1. 99. Kiiskinen U, Vartiainen E, Puska P ym. Long- term cost and life- expectancy consequences of hypertension. J Hypertens 1. 99. Long- term cost and life- expectancy consequences of hypertension. J Hypertens 1. 99. Muut syd. An updated coronary risk profile. A statement for health professionals. Circulation 1. 99. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1. 99. 6; 2. Mancia G, De Backer G, Dominiczak A ym. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension »1. Koska my. Kansallinen FINRISKI 2. Osa 2: Tutkimuksen taulukkoliite. Terveyden ja hyvinvoinnin laitos, Raportti 2. Terveys 2. 00. 0 - tutkimuksen perustulokset. Kansanterveyslaitoksen julkaisuja B3/2. Helsinki 2. 00. 2»2. Kuulasmaa K, Tunstall- Pedoe H, Dobson A ym. Estimation of contribution of changes in classic risk factors to trends in coronary- event rates across the WHO MONICA Project populations. Lancet 2. 00. 0; 3. Continuous 1. 5- year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke 2. 00. 4; 3. Puska P, Vartiainen E, Laatikainen T, Jousilahti P, Paavola M (toim.). The North Karelia Project: From North Karelia to national action. Terveyden ja hyvinvoinnin laitos. Helsinki University Printing »7, «Salomaa V, Ketonen M, Koukkunen H ym. Decline in out- of- hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among pers»2. Vartiainen E, Puska P, Pekkanen J ym. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1. 99. 4; 3. 09: 2. Taulukko 1. SVP = systolinen verenpaine DVP = diastolinen verenpaine (mm. Hg) 1 Ik. 2 Ohitusleikkaus tai sepelvaltimoiden pallolaajennus, l. Kotimittaus on suositeltavin ja useimmiten riitt. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from »2. Verenpaine voidaan mitata oikeasta tai vasemmasta olkavarresta, vaikka oikeasta olkavarresta mitattu verenpaine on keskim. Inter- arm differences in blood pressure: when are they clinically significant? J Hypertens 2. 00. Kimura A, Hashimoto J, Watabe D ym. Patient characteristics and factors associated with inter- arm difference of blood pressure measurements in a general population in Ohasama, Japan. J Hypertens 2. 00. Johansson JK, Puukka PJ, Jula AM. Interarm blood pressure difference and target organ damage in the general population. Kotimittaukset ja verenpaineen vuorokausirekister. Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. BMJ 2. 00. 1; 3. 22: 9. Mansetin kumipussi. Koko on ohjeen mukainen: leveys v. Tutkittavaa ei saa kuormittaa fyysisesti eik. Mittaustapa. Auskultaatiomittauksessa painetta nostetaan v. Janus faces of the white coat effect: blood pressure not only rises, it may also fall. J Hum Hypertens 2. Terveydenhuollon itsemittauspisteiden mittaustulokset n. Janus faces of the white coat effect: blood pressure not only rises, it may also fall. J Hum Hypertens 2. Ortostaattisen hypotension toteamiseksi verenpaine mitataan i. Daytime and nighttime blood pressure as predictors of death and cause- specific cardiovascular events in hypertension. Hypertension 2. 00. Angelousi A, Girerd N, Benetos A ym. Association between orthostatic hypotension and cardiovascular risk, cerebrovascular risk, cognitive decline and falls as well as overall mortality: a systematic r»3. Ortostaattisessa hypotensiossa systolinen verenpaine alenee v. Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring. Hypertension 1. 99. Office, Home, and Ambulatory Blood Pressures as Predictors of Cardiovascular Risk. Hypertension 2. 01. Verenpaineen kotimittaus. Kotona itse tehdyt verenpainemittaukset kuvaavat luotettavammin tavanomaista painetasoa ja kohde- elinvaurioiden vaaraa kuin vastaanotto- oloissa tehdyt kertamittaukset «Parati G, Stergiou GS, Asmar R ym. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pr»3. Pickering TG, Miller NH, Ogedegbe G ym. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society O»3. Office, Home, and Ambulatory Blood Pressures as Predictors of Cardiovascular Risk. Hypertension 2. 01. Niiranen TJ, H. Home- measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn- Home study. Hypertension 2. 01. Niiranen TJ, Asayama K, Thijs L ym. Outcome- driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension 2. 01»4. Verenpaine ja syke mitataan aamulla kello 6–9 ja illalla kello 1. Iltamittausten tasoa korkeampi aamumittausten taso voi viitata uniapneaan tai runsaaseen alkoholink. Factors affecting the difference between morning and evening home blood pressure: the Finn- Home study. Blood Press 2. 01. Nelj. Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring. Hypertension 1. 99. Niiranen TJ, Johansson JK, Reunanen A ym. Optimal schedule for home blood pressure measurement based on prognostic data: the Finn- Home Study. Hypertension 2. 01. L. Ambulatory blood pressure monitoring and blood pressure self- measurement in the diagnosis and management of hypertension. Ann Intern Med 1. Diagnostic thresholds for ambulatory blood pressure monitoring based on 1. Circulation 2. 00. Vuorokausirekister. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow- up results from the Pressioni Arterios»4. Fagard RH, Celis H, Thijs L ym. Daytime and nighttime blood pressure as predictors of death and cause- specific cardiovascular events in hypertension. Hypertension 2. 00. Hansen TW, Li Y, Boggia J ym. Predictive role of the nighttime blood pressure. Hypertension 2. 01. Diagnostic thresholds for ambulatory blood pressure monitoring based on 1. Circulation 2. 00. Niiranen TJ, Asayama K, Thijs L ym. Outcome- driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension 2. 01»4. Verenpainetaso ja verenpaineen luokittelu varmistetaan elintapahoidon aikana kotimittauksella tai pitk. Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn- HOME study. J Hypertens 2. 00. Valkotakkihypertensitiivisten elintavat ovat keskim. Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn- HOME study. J Hypertens 2. 00. Metabolisia riskitekij. Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn- HOME study. J Hypertens 2. 00. Valkotakkihypertensio ennakoi vakiintuneen hypertension ilmaantumista «Ugajin T, Hozawa A, Ohkubo T ym. White- coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med 2. Valkotakkihypertensioon liittyv. J Am C»5. 1 mutta suurempi kuin normotensioon liittyv. Prognosis of white- coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension 2. 01. Verdecchia P, Reboldi GP, Angeli F ym.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2017
Categories |